Press release
Alpha-Synuclein (AlphaSyn Or SNCA) - Pipeline Review, H1 2016
"The Report Alpha-Synuclein (alphaSyn or SNCA) - Pipeline Review, H1 2016 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"Description
Alpha-Synuclein (alphaSyn or SNCA) - Pipeline Review, H1 2016
Summary
Global Markets Directs, Alpha-Synuclein (alphaSyn or SNCA) - Pipeline Review, H1 2016, provides in depth analysis on Alpha-Synuclein (alphaSyn or SNCA) targeted pipeline therapeutics.
The report provides comprehensive information on the Alpha-Synuclein (alphaSyn or SNCA), targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Alpha-Synuclein (alphaSyn or SNCA) targeted therapeutics development and features dormant and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
View Report At: http://www.marketresearchreports.biz/analysis/774397
Scope
- The report provides a snapshot of the global therapeutic landscape for Alpha-Synuclein (alphaSyn or SNCA)
- The report reviews Alpha-Synuclein (alphaSyn or SNCA) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Alpha-Synuclein (alphaSyn or SNCA) targeted therapeutics and enlists all their major and minor projects
- The report assesses Alpha-Synuclein (alphaSyn or SNCA) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Alpha-Synuclein (alphaSyn or SNCA) targeted therapeutics
Download Detail Report With Complete TOC at: http://www.marketresearchreports.biz/sample/sample/774397
Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Alpha-Synuclein (alphaSyn or SNCA)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Alpha-Synuclein (alphaSyn or SNCA) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Browse all latest Press Releases of Market Research Reports
at: http://www.marketresearchreports.biz/pressreleases
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time and money for our clients.
We are a one stop solution for all your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting services. We serve all sizes and types
of companies spanning across various industries.
Contact
Mr. Nachiket
90 Sate Street,
Suite 700 Albany,
NY 12207 USA
Tel: +1-518-621-2074
Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz
Follow us on LinkedIn: https://www.linkedin.com/company/marketresearchreports-biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Alpha-Synuclein (AlphaSyn Or SNCA) - Pipeline Review, H1 2016 here
News-ID: 355773 • Views: …
More Releases from MarketResearchReports.biz
Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in…
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume…
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with…
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is…
More Releases for SNCA
Parkinson's Disease Clinical and Non-Clinical Studies, Key Companies, Therapeuti …
DelveInsight's, "Parkinson's Disease- Pipeline Insight, 2025" report provides comprehensive insights about 130+ companies and 150+ pipeline drugs in Parkinson's Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
According to DelveInsight, over 130 prominent companies are actively involved in…
Parkinson's Disease Clinical Pipeline | 130+ Companies Advancing the Future of T …
The Parkinson's Disease market is rapidly evolving with cutting-edge research and breakthrough therapies, driven by leading companies like ANEW MEDICAL, Longevity Biotech, Minerva Neurosciences/Mitsubishi Tanabe Pharma Corporation, Tetraneuron, and Kallyope. These innovators are revolutionizing treatment approaches and shaping the future of Parkinson's disease care, offering new hope for patients worldwide.
DelveInsight's 'Parkinson's Disease Pipeline Insight 2024' report provides comprehensive global coverage of pipeline Parkinson's Disease therapies in various stages of clinical…
Parkinson's Disease Clinical and Non-Clinical Studies, Key Companies, Therapeuti …
Parkinson's Disease Pipeline constitutes 130+ key companies continuously working towards developing 150+ Parkinson's Disease treatment therapies, analyzes DelveInsight.
Parkinson's Disease Overview:
Parkinson's disease (PD) is a chronic, progressive neurological disorder that primarily affects movement, due to the loss of dopamine-producing neurons in the substantia nigra, a brain area responsible for motor control. It typically develops in people over 60 but can occur earlier. PD is the second most common neurodegenerative disease after…
Alpha Synuclein Market Size, Share, Analysis, Industry Report and Forecast 2022- …
The global alpha-synuclein market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Alpha-synuclein is a neuronal protein that is encoded by the SNCA gene in humans and is abundant in the brain, while smaller amounts of it are found in the heart, muscle, and other tissues. Alpha-synuclein is a protein that regulates synaptic vesicle trafficking and subsequent neurotransmitter release. Abnormal alpha-synuclein depositions (?-synucleinopathies) in neurons,…
Alpha-Synuclein Inhibitor Therapeutics -Clinical Trials & Results | AC Immune, N …
Alpha-synuclein is a protein that is abundantly found in the brain. The minimal amount of alpha-synuclein is also found in the heart and other tissues. The protein is prominently found at the tips of the nerve cells. It helps in the maintaining supply of the synaptic vesicle in presynaptic terminals.
Download the sample report @ https://www.pharmaproff.com/request-sample/1170
In addition, the alpha-synuclein protein also helps in release of dopamine. The protein comprised of…
